These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1562715)
21. [Correlations between sonographic and clinical findings in breast cancer]. Stosiek U; Zedelius M Ultraschall Med; 1986 Aug; 7(4):185-8. PubMed ID: 3024315 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast. Sapino A; Papotti M; Pietribiasi F; Bussolati G Virchows Arch; 1998 Sep; 433(3):217-22. PubMed ID: 9769124 [TBL] [Abstract][Full Text] [Related]
23. Cytological grading of duct cell carcinoma, NOS of breast and its correlation with histological grading. Sultana T; Rahman AJ Bangladesh Med Res Counc Bull; 2006 Aug; 32(2):49-54. PubMed ID: 17663360 [TBL] [Abstract][Full Text] [Related]
24. Typing and grading of cytological category C5 breast lesions. Zafar N; Jamal S; Mamoon N; Luqman M; Anwar M J Coll Physicians Surg Pak; 2005 Apr; 15(4):221-4. PubMed ID: 15857595 [TBL] [Abstract][Full Text] [Related]
25. Cytological study of 20 cases of solid-papillary carcinoma of the breast. Yamada M; Otsuki Y; Shimizu S; Tanioka F; Ogawa H; Kobayashi H Diagn Cytopathol; 2007 Jul; 35(7):417-22. PubMed ID: 17580353 [TBL] [Abstract][Full Text] [Related]
26. [Usefulness of cytoprognostic classification combined with histoprognostic classification in breast cancer]. Seigneurin D; Louis J; Seigneurin D Bull Assoc Anat (Nancy); 1993 Sep; 77(238):33-6. PubMed ID: 8148524 [TBL] [Abstract][Full Text] [Related]
27. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions. Masood S Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088 [TBL] [Abstract][Full Text] [Related]
28. Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading. Martinazzi M; Crivelli F; Zampatti C; Pisani P Pathologica; 1992; 84(1089):33-47. PubMed ID: 1323096 [TBL] [Abstract][Full Text] [Related]
29. A morphometric approach in breast cytology--geometrical descriptors in the differentiation between benign and malignant lesions. Mihalache D; Giuşcă SE; Balan R; Amălinei C; Grigoraş A; Căruntu ID Rom J Morphol Embryol; 2014; 55(2):273-7. PubMed ID: 24969974 [TBL] [Abstract][Full Text] [Related]
30. Utility of different immunostains for diagnosis of metastatic breast carcinomas in both surgical and cytological specimens. Hou Y; Shen R; Chaudhary S; Tonkovich D; Li Z Ann Diagn Pathol; 2017 Oct; 30():21-27. PubMed ID: 28965624 [TBL] [Abstract][Full Text] [Related]
31. Typing and grading breast carcinoma on fine-needle aspiration: is this clinically useful information? Robinson IA; McKee G; Kissin MW Diagn Cytopathol; 1995 Oct; 13(3):260-5. PubMed ID: 8575287 [TBL] [Abstract][Full Text] [Related]
32. Intralaboratory variations in the grading of breast carcinoma. Delides GS; Garas G; Georgouli G; Jiortziotis D; Lecca J; Liva T; Elemenoglou J Arch Pathol Lab Med; 1982 Mar; 106(3):126-8. PubMed ID: 6895838 [TBL] [Abstract][Full Text] [Related]
33. Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions. Thomas JS; Mallon EA; George WD J Clin Pathol; 1989 Jan; 42(1):28-34. PubMed ID: 2537853 [TBL] [Abstract][Full Text] [Related]
34. Stereotactic fine needle aspiration biopsy (SFNB) of breast: preliminary results in Perth with the TRC mammotest machine. Cytological aspects. Sterrett G; Oliver D; Frayne J; Ingram D; Sheiner H Pathology; 1991 Oct; 23(4):302-10. PubMed ID: 1664514 [TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical expression of E-cadherin on fine-needle aspirates from breast carcinomas correlate with the cell dissociation pattern seen on smears. Sauer T; Boudjema G; Jebsen PW; Naess O Diagn Cytopathol; 2001 Dec; 25(6):382-8. PubMed ID: 11747235 [TBL] [Abstract][Full Text] [Related]
36. Role of nuclear grading of breast carcinomas in fine needle aspiration specimens. Dabbs DJ Acta Cytol; 1993; 37(3):361-6. PubMed ID: 8498137 [TBL] [Abstract][Full Text] [Related]
37. Lobular carcinoma of the breast: cytological features supporting the diagnosis of lobular cancer. Robinson IA; McKee G; Jackson PA; Cook MG; Kissin MW Diagn Cytopathol; 1995 Oct; 13(3):196-201. PubMed ID: 8575277 [TBL] [Abstract][Full Text] [Related]
38. Objective quantitative grading. A study of breast ductal hyperplasias and ductal carcinomas in situ. Mariuzzi G; Mombello A; Mariuzzi L; Thompson D; Bartels PH Ann N Y Acad Sci; 1996 Apr; 784():395-402. PubMed ID: 8651587 [No Abstract] [Full Text] [Related]
39. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast. Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154 [TBL] [Abstract][Full Text] [Related]
40. [Locally and regionally limited breast cancer from the pathologist's view point]. Gloor F Schweiz Med Wochenschr; 1977 Jul; 107(28):969-72. PubMed ID: 897635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]